Business
Currency:USD
2025/Q2
Stock NameRevenueRatio
United States (US) Pharmaceutical85.73B91.54%
International3.71B3.96%
Medical-Surgical Solutions2.95B3.15%
Prescription Technology Solutions1.27B1.35%
Corporate3M0.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States294.82B95.43%
International14.13B4.57%
